ライフサイエンスコーパス: TLR5

1 llin recognized by the Toll-like receptor 5 (TLR5).

2 imal husbandry practices rather than loss of TLR5.

3 h concomitant TLR6 mutation), 1 IRAK1, and 1 TLR5.

4 erated C57BL/6 mice with LoxP sites flanking Tlr5.

5 main with the convex surface of the opposing TLR5.

6 V sequence and increased association of MUC1/TLR5.

7 ost immunity, in part via its recognition by TLR5.

8 ing the dependence of IL-1beta production on TLR5.

9 cells lining the renal vasculature expressed TLR5.

10 red monocyte-derived dendritic cells through TLR5.

11 ary responses or recognition of flagellin by TLR5.

12 ng was assessed with HEK293 cells expressing TLR5.

13 ells but does not affect activation of human TLR5.

14 nd most CD172alpha(+)LPDCs also co-expressed TLR5.

15 r of which is incapable of signaling through TLR5.

16 flagellin or heat-killed B. pseudomallei by TLR5(1174C)>T genotype in healthy subjects.

17 lude that the hypofunctional genetic variant TLR5(1174C)>T is associated with reduced organ failure a

18 In a dominant model, TLR5(1174C)>T was associated with protection against in-

19 We tested the association of TLR5(1174C)>T with outcome in 600 Thai subjects with mel

20 riant that encodes a defective TLR5 protein, TLR5(1174C)>T, to elucidate the role of TLR5 in melioido

21 TLR5 and found that B. pseudomallei induced TLR5(1174C)- but not TLR5(1174T)-dependent activation of

22 ers of TLR5(1174T) compared with carriers of TLR5(1174C).

23 e those in TLR1 (1805GG), TLR2 (2258GA), and TLR5 (1174CT).

24 , IL-1ra, G-CSF, and IL-1beta in carriers of TLR5(1174T) compared with carriers of TLR5(1174C).

25 B. pseudomallei induced TLR5(1174C)- but not TLR5(1174T)-dependent activation of NF-kappaB.

26 te-normalized levels of IL-10 in carriers of TLR5(1174T).

27 entrations further decreased (p < 0.05) in a TLR5(392Stop) SNP rUTI subgroup.

28 beta mRNA in human primary immune cells from TLR5 616LL homozygote carriers, as compared with 616FF c

29 ortance of TLR5 function in RA, we used anti-TLR5 Ab therapy in CIA mice.

30 l inputs from Toll-like receptor 5-positive (TLR5(+)) Abeta low-threshold mechanoreceptors and is dir

31 s that neutralized the Toll-like receptor 5 (TLR5)-activating activity of flagellin, an important par

32 These findings indicate that TLR5 activation by flagellin mediates innate immune resp

33 ylori and Campylobacter jejuni, have escaped TLR5 activation by mutations in this epitope.

34 TLR5 activation in MCF7 cells induced a single and susta

35 aeruginosa or different mutants defective in TLR5 activation were resistant to AM phagocytosis and ki

36 is functional, we compared human and bovine TLR5 activity and signalling in cognate cell lines.

37 he ability of flagellated isolates to induce TLR5 activity.

38 count: TLR4 (aGMR, 1.22; 95% CI, 1.03-1.45), TLR5 (aGMR, 1.19; 95% CI, 1.01-1.41), and TLR6 (aGMR, 1.

39 Impact of a TLR5 agonist (flagellin; FliC) on vaccine efficacy and i

40 s also stimulated hepcidin, most notably the TLR5 agonist flagellin in an IL-6-dependent manner.

41 The TLR5 agonist flagellin is a potent adjuvant and is curre

42 harmacologically optimized derivative of the TLR5 agonist flagellin.

43 sive activity of entolimod, a clinical stage TLR5 agonist that activates NF-kappaB-, AP-1-, and STAT3

44 n structurally analogous to a clinical stage TLR5 agonist, entolimod.

45 enicity of recombinant proteins containing a TLR5 agonist, flagellin, and either full-length or selec

46 We show that TLR5 agonist, flagellin, can promote monocyte infiltrati

47 protective effects of pretreatment with the TLR5 agonist, indicating a window following reperfusion

48 guing observation as C. jejuni FlaA is not a TLR5 agonist.

49 viral activity was the Toll-Like Receptor 5 (TLR5) agonist flagellin.

50 a-derived flagellin, a Toll-like receptor 5 (TLR5) agonist, protects mice from C. difficile colitis b

51 bility of flagellin, a Toll-like receptor 5 (TLR5) agonist, to serve as an effective adjuvant in this

52 n vivo and suggest clinical applications for TLR5 agonists as hepatoprotective and antimetastatic age

53 Overall, these results indicate the use of TLR5 agonists as mitigators and protectants of acute ren

54 ese results define systemically administered TLR5 agonists as organ-specific immunoadjuvants, enablin

55 Anticancer efficacy of TLR5 agonists stems from TLR5-dependent activation of nu

56 TLR5 agonists, bacterial flagellin and engineered flagel

57 no effect on stimulation by TLR2, TLR3, and TLR5 agonists.

58 Toll-like receptor 5 (TLR5) agonists are favorably positioned as potential sys

59 MyD88-dependent stimulation of TLR1/2 and TLR5 also upregulated PD-L1 expression on CMFs in cultur

60 th PAK mutants or in WT PAK-infected primary TLR5(-/-) AMs, demonstrating the dependence of IL-1beta

61 TLR5 signaling cassette comprising of human TLR5 and a secreted derivative of Salmonella flagellin s

62 Higher gene expression levels in TLR5 and CCR1 are associated with lower lung function an

63 Although both TLR5 and CD172alpha(+) lamina propria dendritic cells (L

64 ammalian species, lack surface expression of TLR5 and do not respond to flagellin.

65 eversibly inhibiting recruitment of MyD88 to TLR5 and downstream signaling events.

66 embryonic kidney-293 cells transfected with TLR5 and found that B. pseudomallei induced TLR5(1174C)-

67 IgG1 was the dominant isotype and partially TLR5 and inflammasome dependent.

68 strate IgG2c responses toward flagellin were TLR5 and inflammasome dependent; IgG1 was the dominant i

69 Here, we studied the functional role of TLR5 and its ligand flagellin in experimental melioidosi

70 ed immunofluorescence colocalization of Muc1/TLR5 and Muc1/phosphotyrosine staining patterns in mouse

71 IgA anti-FliC responses were TLR5 and MyD88 dependent and caspase-1 independent.

72 al signals provided by the gut flora through TLR5 and MyD88 signaling.

73 ng and not through stimulatory signaling via TLR5 and MyD88.

74 that activates the innate immune system via TLR5 and Naip5/6, and generates strong T and B cell resp

75 protein, MRx0518 flagellin was shown to be a TLR5 and NF-kappaB activator in reporter cells and an in

76 eptors (PRRs) are (i) flagellin, detected by TLR5 and NLRC4 (Ipaf); and (ii) T3S rod proteins (PrgJ a

77 ed a correlation between early expression of TLR5 and the magnitude of the antibody response.

78 olymorphisms (SNP) in the flagellin receptor TLR5 and the TLR downstream effector molecules MyD88 and

79 TLR3, TLR7 and TLR9, but not to TLR2, TLR4, TLR5 and TLR8 ligands.

80 We found that TLR5 and TNF-alpha pathways are interconnected, because

81 synovial fluid and the strong correlation of TLR5 and TNF-alpha with each other and with disease acti

82 e, we report that immunization of wild-type, TLR5(-/-), and MyD88(-/-) adoptive transfer recipient mi

83 ed flagellin receptors Toll-like receptor 5 (TLR5) and NOD-like receptor C4 (NLRC4).

84 nsynonymous variant in Toll-like receptor 5 (TLR5) and show that it leads to altered NF-kappaB signal

85 TLR signaling, including elevation of TLR4, TLR5, and IL-1R1, with decreases in IL-1R-associated kin

86 LPDCs expressed high levels of TLR5, and most CD172alpha(+)LPDCs also co-expressed TLR5

87 Using two tumor models that do not express TLR5, and thereby do not directly respond to CBLB502, we

88 ck of CTSK inhibited the expression of TLR4, TLR5, and TLR9 and their downstream cytokine signaling i

89 Human TLR2, TLR4, TLR5, and TLR9 gene polymorphisms were assessed in 278 H

90 Comparison of MyD88-, TLR2-, TLR4-, TLR5-, and TLR9-deficient mice and their respective wild

91 Wild-type and TLR5(-/-) APCs were able to stimulate high levels of OVA

92 which multiple TLR pathways (e.g., TLR2/TLR4/TLR5) are blocked are not as compromised in their respon

93 Here, we report that, in contrast to TLR5 as a "carrier of Salmonella," TLR11 works as a "blo

94 etermined the crystal structure of zebrafish TLR5 (as a variable lymphocyte receptor hybrid protein)

95 r protein MyD88 is critical for signaling by TLR5, as well as IL-1Rs and IL-18Rs, major downstream me

96 Toll-like receptor 5 (TLR5) binding to bacterial flagellin activates signaling

97 that exploit pathogen recognition elements, TLR5 biosensors have the potential to carry out broad-sp

98 uilding on our previous research that bovine TLR5 (bTLR5) is functional, we compared human and bovine

99 , to generate mice that lacked expression of TLR5 by IECs (TLR5(DeltaIEC)) or DCs (TLR5(DeltaDC)), re

100 Scarified corneas of adult B6, TLR5(-/-), Camp(-/-) (cathelicidin-related antimicrobial

101 ) and FVC were lower in the highest level of TLR5 compared to the lowest quartile with difference of

102 n of flagellin via the Toll-like receptor 5 (TLR5) contributes to exacerbate B. cenocepacia-induced l

103 allei In conclusion, these data suggest that TLR5 deficiency has a detrimental flagellin-independent

104 xt, we found that B. pseudomallei-challenged TLR5-deficient (Tlr5(-/-) ) mice were more susceptible t

105 2alpha(-), LPDCs induced Th17 cells, whereas TLR5-deficient LPDC did not induce Th17 cells.

106 Ex vivo experiments showed that TLR5-deficient macrophages display markedly impaired pha

107 Flagellin receptor TLR5-deficient mice (T5KO) display elevated intestinal p

108 ory phenotype is not a consistent feature of TLR5-deficient mice and document a novel role for TLR5 i

109 However, we report that TLR5-deficient mice from two different animal colonies d

110 TLR5-deficient mice have been reported to develop sponta

111 europathy, but this blockade is abrogated in Tlr5-deficient mice.

112 ion of TLR5 by IECs (TLR5(DeltaIEC)) or DCs (TLR5(DeltaDC)), respectively.

113 ar to previous findings from TLR5-null mice, TLR5(DeltaIEC) mice had low-grade inflammation (mild spl

114 Development of this inflammation in the TLR5(DeltaIEC) mice was eliminated by administration of

115 mice that lacked expression of TLR5 by IECs (TLR5(DeltaIEC)) or DCs (TLR5(DeltaDC)), respectively.

116 cells in a temperature-dependent manner via TLR5-dependent activation of NF-KappaB.

117 icancer efficacy of TLR5 agonists stems from TLR5-dependent activation of nuclear factor-kappaB (NF-k

118 able lidocaine derivative QX-314, leading to TLR5-dependent blockade of sodium currents, predominantl

119 We report that TLR5-dependent commensal bacteria drive malignant progre

120 y, depletion of commensal bacteria abrogates TLR5-dependent differences in tumor growth.

121 ults define the liver as the key mediator of TLR5-dependent effects in vivo and suggest clinical appl

122 lin, AECs trigger the release of GM-CSF in a TLR5-dependent fashion and the doubling of the number of

123 icrobe, Tyler et al. (2013) demonstrate that TLR5-dependent induction of anti-flagellin antibodies pr

124 nd protection against Candida keratitis in a TLR5-dependent manner.

125 omotes the development of allergic asthma by TLR5-dependent priming of allergic responses to indoor a

126 the MLN, but not the spleen, sFliC drives a TLR5-dependent recruitment of CD103(+) dendritic cells (

127 CBLB502 is a novel agonist for TLR5 derived from Salmonella flagellin.

128 In vitro, the level of TLR5 downstream genes, IL-6 and IL-8, was highly induced

129 t unlike the Salmonella Typhimurium flagella-TLR5 driven pro-inflammatory axis, C. jejuni flagella in

130 ct and an indirect mechanism are involved in TLR5-driven RA inflammation and bone destruction.

131 cular mechanism that PTEN deletion inhibited TLR5-elicited responses, we hypothesized that PTEN regul

132 Here, we report that TLR5 engagement is crucial for bacterial clearance by AM

133 Altogether, these findings demonstrate that TLR5 engagement plays a major role in P. aeruginosa inte

134 ses by controlling the involvement of Mal in TLR5 engagement.

135 The residues in the C. jejuni TLR5 epitope have reduced contacts with the adjacent sub

136 interface introduced by the mutations in the TLR5 epitope is compensated for by extensive interaction

137 the flagellin receptor Toll-like receptor 5 (TLR5) exhibit a profound loss of flagellin-specific immu

138 Significant sequence variation in TLR5 exists between animal species but its impact on act

139 owed that interactions between flagellin and TLR5 expressed on both donor hematopoietic and host nonh

140 tion of TLR5 signaling can inhibit growth of TLR5-expressing tumors and protect normal tissues from r

141 ation with neither LPS nor IFN-gamma altered TLR5 expression by the monocytes.

142 ly, TNF-alpha has a feedback regulation with TLR5 expression in RA monocytes, whereas expression of t

143 anti-TNF-alpha therapy can markedly suppress TLR5 expression in RA monocytes.

144 First, we observed differential TLR5 expression in the pulmonary and hepatic compartment

145 aeruginosa bacteria, and 3) corresponded to TLR5 expression on MDSCs in vitro and in vivo.

146 r of TNF-alpha in RA synovial fluid and that TLR5 expression on these cells strongly correlates with

147 Tlr5(fl/fl) siblings were used as controls.

148 Indeed, by activating the TLR5, flagella can elicit activation of the MAPK and NF-

149 ctural basis and mechanistic implications of TLR5-flagellin recognition, we determined the crystal st

150 Two TLR5-FliC 1:1 heterodimers assemble into a 2:2 tail-to-t

151 Loss of TLR5 from DCs did not associate with development of infl

152 Last, to evaluate the importance of TLR5 function in RA, we used anti-TLR5 Ab therapy in CIA

153 mmation and bone erosion are alleviated when TLR5 function is blocked.

154 hus, in contrast to T5KO mice, loss of human TLR5 function protects from weight gain, but in analogy

155 (R392X, rs5744168), a portion of humans lack TLR5 function.

156 These two identified TLR5 functions are potentiated by TNF-alpha, because inh

157 In the context that TLR5 functions to recognize pathogens and activate innat

158 The TLR5 gene encodes an innate immunity receptor.

159 Increased TLR4 and TLR5 gene expression in whole blood was demonstrated in

160 In the TLR5 gene, rs5744174/F616L was associated with increased

161 ctal cancer progression might be mediated by TLR5 genotype-dependent flagellin sensing.

162 oteobacteria evading antibody coating in the TLR5(-/-) gut.

163 Loss of TLR5 has more impact on MLN than splenic Ab responses, r

164 el biosensor utilizing toll-like receptor 5 (TLR5) has been conducted.

165 and IL-8, was highly induced by flagellin in TLR5 high-expressing cells compared with TLR5 low-expres

166 In contrast, the absence of TLR5 hindered the initial activation and clonal expansio

167 members overexpressed flagellar genes in the TLR5(-/-) host.

168 and reciprocal results were found for human TLR5 (hTLR5) in human cells, indicative of host cell spe

169 atory effects were dramatically inhibited in TLR5(-/-);IL-10(-/-) mice.

170 These data show complex roles for TLR4, TLR5, IL-1R and CD11c+ cells in constitutive epithelial

171 of the modified bare gold surface following TLR5 immobilization were characterized.

172 The MUC1 cytoplasmic tail associated with TLR5 in all cells tested, including HEK293T cells, human

173 e generated mice with specific disruption of Tlr5 in IECs or DCs by using a breeding scheme that allo

174 es of plasma cells, demonstrating a role for TLR5 in immunity to TIV.

175 epithelial cell (IEC) vs dendritic cell (DC) TLR5 in mediating these phenotypes are not clear; modifi

176 ein, TLR5(1174C)>T, to elucidate the role of TLR5 in melioidosis.

177 ght to establish the role of TLR2, TLR4, and TLR5 in postseptic mice with Pseudomonas aeruginosa pneu

178 deficient mice and document a novel role for TLR5 in the rapid targeting of flagellin by intestinal p

179 TCL1A, TMEM176B, FOXP3, TOAG-1, MAN1A1, and TLR5) in the peripheral blood of 67 kidney transplant re

180 controlling Mal recruitment, PTEN regulates TLR5-induced inflammatory responses.

181 sponses, we hypothesized that PTEN regulated TLR5-induced responses by controlling the involvement of

182 al-TLR5 interaction, resulting in diminished TLR5-induced responses.

183 in, the sole ligand of Toll-like receptor-5 (TLR5), induces an innate defense that is sufficient to p

184 rotein that stimulates Toll-like receptor 5 (TLR5), induces epithelial expression of RegIIIgamma and

185 specific IgG1 response was induced through a TLR5-, inflammasome-, and MyD88-independent pathway.

186 Furthermore, PTEN deletion disrupted Mal-TLR5 interaction, resulting in diminished TLR5-induced r

187 on at the plasma membrane and suppressed Mal-TLR5 interaction.

188 TLR5 interacts primarily with the three helices of the F

189 TLR5 is a pathogen recognition receptor activated by bac

190 In this study, we show that TLR5 is elevated in RA and osteoarthritis ST lining and

191 Furthermore, expression of TLR5 is elevated in RA synovial fluid macrophages and RA

192 In patients with melioidosis, TLR5 is the most abundantly expressed TLR, and a hypofun

193 ver, the regulation and pathogenic effect of TLR5 is undefined in RA.

194 We found that Toll-like receptor 5 (TLR5) is co-expressed with neurofilament-200 in large-di

195 Toll-like receptor 5 (TLR5) is considered an attractive target for anticancer

196 neutrophils and monocytes expressed mRNA for TLR5, it appeared to be translated into protein only by

197 radiation chimeras previously engrafted with TLR5 knockout hematopoietic cells showed that interactio

198 engineered to secrete bacterial flagellin, a TLR5 ligand (TLR5L), can engender a costimulatory signal

199 Cross-tolerance was observed by TLR5 ligand flagellin and heat-killed or live bacteria r

200 ed T-84 cells treated basolaterally with the TLR5 ligand flagellin was prevented when the polarized c

201 id affect IL-12 or IL-1beta induction by the TLR5 ligand flagellin.

202 ide (LPS, both TLR4 ligands), and flagellin (TLR5 ligand).

203 HCMV infection also potentiated TLR5 ligand-stimulated cytokine production.

204 Fas in IECs reduced the ability of TLR4 and TLR5 ligands and the intestinal pathogens Salmonella typ

205 on with Toll-like receptor (TLR) 2, TLR4, or TLR5 ligands than blood from APOepsilon3/APOepsilon3 pat

206 Treatment with TLR4 and TLR5 ligands, but not TLR2 and 9 ligands, increased expr

207 teoclast maturation directly through myeloid TLR5 ligation and indirectly via TNF-alpha production fr

208 cytes and macrophages are more responsive to TLR5 ligation compared with fibroblasts despite the proi

209 onclusion, we document the potential role of TLR5 ligation in modulating transcription of TNF-alpha f

210 rconnected, because TNF-alpha is produced by TLR5 ligation in RA myeloid cells, and anti-TNF-alpha th

211 Our aim was to examine the impact of TLR5 ligation in rheumatoid arthritis (RA) and experimen

212 agellin postonset treatment in CIA and local TLR5 ligation in vivo provoke homing and osteoclastic de

213 TLR2 and TLR5 ligation increased beta2-integrin affinity, as asse

214 agen-induced arthritis (CIA) and local joint TLR5 ligation models.

215 es were conducted to investigate the role of TLR5 ligation on RA and mouse myeloid cell chemotaxis or

216 TLR2 or TLR5 ligation rapidly activated integrin-dependent leuko

217 in TLR5 high-expressing cells compared with TLR5 low-expressing cells.

218 Our results suggest that expression of TLR5 may be a predictor for RA disease progression and t

219 onses, the smoking-induced downregulation of TLR5 may contribute to smoking-related susceptibility to

220 or RA disease progression and that targeting TLR5 may suppress RA.

221 TLR5-mediated Abeta-fiber blockade, but not capsaicin-me

222 aB transcriptional activity while increasing TLR5-mediated AP-1 transcription.

223 eficial effect of CBLB502, and suggests that TLR5-mediated immune modulation may be a promising appro

224 tool for antitumor vaccination that directs TLR5-mediated immune response toward cancer cells and do

225 On the basis of TLR5-mediated immunomodulatory function, we examined the

226 er the significance of TNF-alpha function in TLR5-mediated pathogenesis.

227 agellin and a cell reporter system to assess TLR5-mediated responses, we also show that the presence

228 TLR5-mediated sensing of flagellin promoted plasma cell

229 Finally, TLR5-mediated sensing of the microbiota also impacted an

230 using agonistic anti-Fas augmented TLR4- and TLR5-mediated TNF-alpha and IL-8 production by IECs.

231 Our data thereby demonstrated that TLR5 mediates CD172alpha(+)LPDC induction of Th17 cells

232 ell development, it is still unclear whether TLR5 mediates the CD172alpha(+)LPDC induction of Th17 ce

233 ia adherent to the corneas of IL-1R (-/-) or TLR5 (-/-) mice penetrated beyond the epithelial surface

234 Postseptic wild-type and tlr4(-/-) and tlr5(-/-) mice displayed high susceptibility to P. aerug

235 Tlr5(-/-) mice showed a similar impaired antibacterial d

236 t B. pseudomallei-challenged TLR5-deficient (Tlr5(-/-) ) mice were more susceptible to infection than

237 mice but not Toll-like receptor 5-deficient (TLR5(-/-)) mice, indicating that they resulted from infl

238 n inhibited flagellin-induced association of TLR5/MyD88 compared with controls.

239 Flagellin functioning via the TLR5/NFkappaB pathway was identified as the key UPEC vir

240 e lacking the receptor Toll-like receptor 5 (TLR5-null mice), which recognizes flagellin, have an alt

241 Similar to previous findings from TLR5-null mice, TLR5(DeltaIEC) mice had low-grade inflam

242 In mice, flagellin activation of TLR5 on DCs leads to production of interleukin-22.

243 Flagellin-induced activation of TLR5 on dendritic cells elicited production of the cytok

244 Mal interacted with TLR5 on flagellin, and Mal deficiency inhibited flagelli

245 Expression of TLR5 on IECs regulates the composition and localization

246 We also found that TLR5 on RA monocytes is an important modulator of TNF-al

247 c CD8(+) T cell proliferation independent of TLR5 or MyD88 expression by the recipient animal.

248 ent on TLR9 signaling and was not induced by TLR5 or other NF-kappaB activators, such as TNF-alpha.

249 Mice deficient solely in TLR2, TLR4, TLR5, or TLR9 did not show enhanced parasite expulsion,

250 se 8 during stimulation of TLR2, TLR3, TLR4, TLR5, or TLR9 results in receptor interacting protein (R

251 djuvant activation of innate immune TLR4 and TLR5 pathways.

252 By recognizing flagellin, TLR5 plays a quintessential role in microbial recognitio

253 f cancer patients are influenced by a common TLR5 polymorphism.

254 In contrast, the TLR2 and TLR5 polymorphisms did not vary in frequency or function

255 lysis and flow cytometry were used to detect TLR5 protein in both cell types.

256 d a genetic variant that encodes a defective TLR5 protein, TLR5(1174C)>T, to elucidate the role of TL

257 ion reduces recognition of flagellin by host TLR5, providing an evasive strategy to infecting bacteri

258 The dominant TLR5(R392X) polymorphism abrogates flagellin responses i

259 Co-expression of TLR5 receptor and agonist in Mobilan-infected cells esta

260 Toll-like receptor 5 (TLR5) recognition of flagellin instigates inflammatory s

261 Vertebrate Toll-like receptor 5 (TLR5) recognizes bacterial flagellin proteins and activa

262 of bacteria that are recognized by TLR4 and TLR5, respectively.

263 ocytic MDSCs cause gammadelta lymphocytes in TLR5-responsive tumors to secrete galectin-1, dampening

264 and malignant evolution are recapitulated in TLR5-responsive/unresponsive ovarian and breast cancer p

265 The T allele at TLR5 rs5744174 (p.Phe616Leu) and the C allele at TLR9 rs

266 The TLR5 rs5744174 T allele carriers have higher PBMCs IFN-g

267 In addition, activation of TLR5 signaling can inhibit growth of TLR5-expressing tum

268 an that drives expression of self-activating TLR5 signaling cassette comprising of human TLR5 and a s

269 Cell, Rutkowski and colleagues indicate that TLR5 signaling deficiency, which occurs in approximately

270 Interestingly, flagellin/TLR5 signaling in breast cancer cells inhibits cell prol

271 s2072493/N592S and rs5744174/F616L modulated TLR5 signaling in response to flagellin or to different

272 ted cells established an autocrine/paracrine TLR5 signaling loop resulting in constitutive activation

273 ghly expressed in breast carcinomas and that TLR5 signaling pathway is overly responsive in breast ca

274 This unique ability of MUC1 to control TLR5 signaling suggests its potential role in the pathog

275 appa B (NF-kappaB) activation (indicative of TLR5 signaling) in tissues and cells of mice treated wit

276 ucidate the mechanism by which MUC1 inhibits TLR5 signaling.

277 trast to most other species, suggesting that TLR5 signalling has evolved differently in ruminants.

278 Here, we characterized the dynamics of TLR5 signalling, responsible for the recognition of flag

279 tases of multiple tumors regardless of their TLR5 status.

280 TLR5 stimulation significantly improves pathological cha

281 Mice lacking Tlr5 (T5KO) develop insulin resistance and increased adi

282 To extend application of TLR5-targeted anticancer immunotherapy to tumors that do

283 sts a deleterious immunoregulatory effect of TLR5 that may be mediated by IL-10 and identifies this r

284 Moreover, Toll-like receptor 5 (TLR5), the mammalian receptor for FLA, was required for

285 ading to an increase in its association with TLR5, thereby competitively and reversibly inhibiting re

286 Wild-type, tlr2(-/-), tlr4(-/-), tlr5(-/-), tlr2 4(-/-) mice that underwent CLP were seco

287 Activation of toll-like receptors (TLR1, TLR5, TLR6) and downstream markers (CCR1, MAPK14, ICAM1)

288 ) or TLR4 (-/-) corneas, but not TLR2 (-/-), TLR5 (-/-), TLR7 (-/-), or TLR9 (-/-), were more suscept

289 with specific ligands for TLR2, TLR3, TLR4, TLR5, TLR7, TLR8 and TLR9 in the presence or absence of

290 l-like receptor 2/6 (TLR2/6), TLR2-CD14, and TLR5 to similar extents in a model cell line.

291 TLR2- and TLR5-triggered integrin activation in leukocytes require

292 ntrast, IL-17 is consistently upregulated in TLR5-unresponsive tumor-bearing mice but only accelerate

293 undantly expressed TLR, and a hypofunctional TLR5 variant has been associated with improved survival.

294 utionary divergence between bovine and human TLR5 was also apparent in relation to responses measured

295 iopsy immunofluorescence studies showed that TLR5 was expressed mainly on the apical side of the epit

296 We found that TLR5 was highly expressed in breast carcinomas and that

297 rapy to tumors that do not naturally express TLR5, we created an adenovirus-based vector for intratum

298 the maintenance of surface CD14 and TLR4 and TLR5, which declined over time in mock-infected macropha

299 nonsmokers, the most striking change was for TLR5, which was downregulated in healthy smokers (1.4-fo

300 Activation of TLR5 with its ligand flagellin results in neuronal entry